Citizens Financial Group Inc. RI Has $21.12 Million Stock Holdings in Stryker Corporation $SYK

Citizens Financial Group Inc. RI boosted its stake in shares of Stryker Corporation (NYSE:SYK) by 3.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 67,075 shares of the medical technology company’s stock after buying an additional 2,464 shares during the period. Citizens Financial Group Inc. RI’s holdings in Stryker were worth $21,118,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Sankala Group LLC acquired a new stake in Stryker during the 4th quarter valued at $26,000. Godfrey Financial Associates Inc. acquired a new position in Stryker during the fourth quarter valued at $26,000. United Financial Planning Group LLC purchased a new stake in Stryker in the 3rd quarter worth about $27,000. Atlas Capital Advisors Inc. purchased a new stake in Stryker in the 4th quarter worth about $27,000. Finally, DJE Kapital AG acquired a new stake in Stryker during the 4th quarter worth about $28,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Wall Street Analysts Forecast Growth

SYK has been the topic of several research analyst reports. Barclays lowered their target price on Stryker from $469.00 to $394.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. BMO Capital Markets began coverage on shares of Stryker in a report on Wednesday, July 8th. They set an “outperform” rating and a $369.00 price target for the company. JPMorgan Chase & Co. lowered their price objective on shares of Stryker from $400.00 to $350.00 and set an “overweight” rating on the stock in a research report on Friday, July 31st. Citizens Jmp dropped their price objective on shares of Stryker from $440.00 to $400.00 and set a “market outperform” rating on the stock in a research note on Monday, August 3rd. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Stryker in a research note on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $386.28.

Insider Buying and Selling at Stryker

In related news, VP Robert S. Fletcher sold 4,544 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $306.87, for a total value of $1,394,417.28. Following the completion of the sale, the vice president directly owned 10,582 shares in the company, valued at approximately $3,247,298.34. This represents a 30.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Ronda E. Stryker sold 310,000 shares of the stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the transaction, the director directly owned 1,924,880 shares in the company, valued at $601,005,282.40. The trade was a 13.87% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 4.60% of the company’s stock.

Stryker Stock Performance

Shares of SYK stock opened at $331.75 on Tuesday. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $396.86. The stock’s 50-day moving average is $325.21 and its two-hundred day moving average is $333.24. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. The firm has a market cap of $127.25 billion, a P/E ratio of 34.38, a PEG ratio of 2.16 and a beta of 0.76.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating the consensus estimate of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The business had revenue of $6.59 billion during the quarter, compared to analysts’ expectations of $6.58 billion. During the same quarter in the previous year, the business posted $3.13 EPS. The firm’s quarterly revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Analysts predict that Stryker Corporation will post 15.02 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a $0.88 dividend. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker’s payout ratio is currently 36.48%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.